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Mesoscopic Multimodal Imaging 
Provides New Insight to Tumor 
Tissue Evaluation: An Example 
of Macrophage Imaging of 
Hepatic Tumor using Organosilica 
Nanoparticles
Michihiro Nakamura1, Koichiro Hayashi2, Hitoshi Kubo3, Masafumi Harada4, Keisuke Izumi5, 
Yoshihiro Tsuruo6 & Toshinobu Yogo2
Multimodal imaging using novel multifunctional nanoparticles provides new approach to biomedical 
field. Thiol-organosilica nanoparticles containing iron oxide magnetic nanoparticles (MNPs) and 
rhodamine B (thiol OS-MNP/Rho) were applied to multimodal imaging of hepatic tumor of Long−Evans 
Cinnamon (LEC) rat. The magnetic resonance imaging (MRI) of LEC rats revealed tumors in the liver 
clearly and semi-quantitatively due to a labeling of macrophages in liver. The fluorescent imaging 
(FI) showed abnormal fluorescent patterns of the liver at the mesoscopic level that was between 
macroscopic and microscopic level. We performed correlation analysis between optical imaging 
including FI and MRI. We found that the labeled macrophages located specific area in the tumor 
tissue and influenced the tumor size on MRI. In addition histological observation showed the labeled 
macrophages related specific tissue in the pathological region. We demonstrated a new approach 
to evaluate tumor tissue at the macroscopic and microscopic level as well as mesoscopic level using 
multimodal imaging.
Multimodal imaging combines two or more imaging modalities into one system and is an important approach 
for advanced imaging studies1–10. Fluorescent imaging (FI) and magnetic resonance imaging (MRI) have unique 
relations because their advantages and disadvantages compensate each other. MRI has various contrasts, such as 
T1 and T2-weighted, and has several advantages: higher spatial resolution and the fact that physiological, molec-
ular, and anatomical information can be extracted simultaneously. However, MRI has relatively low sensitivity 
and a long scan time and large quantity of probe may be needed. FI has already been developed for in vitro and in 
vivo applications. Notable advantages of FI are high temporal resolution, high sensitivity, multichannel imaging 
using multiple fluorescent probes, and relatively low-cost. However, FI in vivo is not quantitative, and the image 
information is surface-weighted. A fusion of the advantages of MRI and FI and their compensation of their dis-
advantages enables the creation of a novel imaging system.
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Recently various types of multimodal imaging nanoparticles (NPs) have been investigated and applied for 
MRI and FI of hepatic tumor11–13. Multimodal imaging NPs containing magnetic nanoparticles (MNPs) and fluo-
rescent nanoparticles (FNPs) can be applied to T2-weighted MRI and FI. In the liver, NPs are rapidly taken up by 
specialized macrophages, Kupffer cells. Imaging of macrophages using their naturally high endocytosis activity 
of NPs is called “macrophage imaging”14. In the hepatic tumor, MNPs increase the contrast between healthy and 
tumor tissue lacking Kupffer cells, because the healthy tissue decreases the signal. Resovist consisting super-
paramagnetic iron oxide nanoparticles coated with carboxydextran has been approved for clinical diagnosis of 
hepatic tumor using MRI. Therefore “macrophage imaging” of hepatic tumor is very useful and practical clinical 
approach. Multimodal imaging of haptic tumor is also investigated and reported11–13. However, importance of 
multimodal “macrophage imaging” to evaluate hepatic tumor tissue has not been reported very well.
We are developing novel types of silica NPs prepared from a single organosilicate and referred as organosilica 
NPs15–19. These organosilica NPs are both structurally and functionally different from typical (inorgano)silica 
particles prepared from tetraethoxyorthosilicate (TEOS). Organosilica NPs can contain not only functional mol-
ecules such as fluorescent dye20, 21 but also nanomaterials22, 23. Functionalized organosilica particles were applied 
for biomedical research such as imaging in vitro20, 22 and in vivo21–25, and single cell analysis26, 27. In addition 
functional molecules and nanomaterials could show new function in organosilica nanoparticles21–23. Recently we 
reported that organosilica NPs containing MNPs and rhodamine B (thiol-OS-MNP/Rho) revealed shortened T2 
relaxation time of MNPs and longer excitation wavelength of rhodamine B23 (Fig. 1). In this paper, we report the 
first usefulness of multimodal imaging of pathological liver in Long−Evans Cinnamon (LEC) rats with a fusion of 
optical imaging including FI and T1- and T2-weighted MRI using thiol-OS-MNP/Rho. These imaging provided 
seamless and sequential “identical” multimodal imaging of tumor tissue from at macroscopic to microscopic level 
including at their intermediate level (mesoscopic imaging). In addition, we demonstrated that “differential” mul-
timodal imaging of hepatic tumor between optical imaging including FI and MRI was also very important to eval-
uate and understand tumor tissue. We discuss a new insight of hepatic tumor tissue using multimodal imaging.
Results and Discussion
Preparation and characterization of thiol-OS-MNP/Rho. Thiol-OS-MNP/Rho (diameter 88 nm) was 
prepared by a one-step, one-pot synthesis using 3-mercaptopropyltrimethoxysilane (MPMS) as the single silica 
source as reported previously23. The formation schema of the thiol-OS-MNP/Rho was shown in Fig. 1A. Thiol 
organosilica layer was formed with rhodamine B after both the hydrolysis and condensation reaction on the sur-
face of EMG707. Thiol-OS-MNP/Rho were monodisperse and contained from one to a few MNPs per particle as 
shown in electron microscopic picture in Fig. 1A.
The T1- and T2-weighted MRI of phantom containing various concentrations of thiol-OS-MNP/Rho 
are shown in Fig. 1Ba. Relaxivities (R1 and R2) of thiol-OS-MNP/Rho of were 3.07 × 10–3 and 2.97 × 10–8 
msec−1·μg·ml−1 respectively. A solution containing 0.1 mg/ml of thiol-OS-MNP/Rho showed fluorescence clearly 
on fluorescent microscopy (Fig. 1Bb). The absorbance spectra of thiol-OS-MNP/Rho showed a peak at 563 nm, 
while rhodamine B appears at 554 nm (Fig. 1Bc). In addition thiol-OS-MNP/Rho showed broad absorbance 
even above 600 nm. Comprehensive 3-dimensional analysis of the excitation, emission, and fluorescence inten-
sities of rhodamine B solution and thiol-OS-MNP/Rho (Fig. 1Bd) were performed. A fluorescence profile of the 
thiol-OS-MNP/Rho was different from that of rhodamine B solution. The rhodamine B solution had excitation/
emission maxima of 550/570 nm. The excitation/emission maxima of the thiol-OS-MNP/Rho were 560/580 nm. 
These results demonstrated that the shift of the absorbance and fluorescence peaks to longer wavelengths were 
observed. Specific emission with excitation above 600 nm was not observed. These results suggested that the 
fluorescent property of rhodamine B was altered in organosilica layer. The organosilica layer has an organosilica 
network connected by a mercaptopropyl chain and is organic/inorganic hybrid structures. Various interactions, 
such as an energy and electron transfer, occur between rhodamine and the organosilica structure. Previously, we 
reported unique changes to the fluorescence properties of QDs22 and propidium iodide21 upon incorporation 
within the thiol-organosilica particle. Their fluorescence profile had an extended range of excitation wavelengths 
toward longer wavelengths. The mechanisms by which rhodamine B as well as other fluorescent molecules in the 
organosilica layer or in organosilica particles alter the fluorescence properties are under investigation.
In vivo MRI of LEC rat injected thiol-OS-MNP/Rho. An LEC rat of approximately 13 months old 
was injected with thiol-OS-MNP/Rho intravenously. The LEC rat has been established from a closed colony of 
Long-Evans rats28. LEC rats develop spontaneous hepatitis approximately 4 months after birth, followed by death 
in 50% of rats due to fulminant hepatitis29, 30. The recovered rat from the fulminant hepatitis exhibited chronic 
hepatitis and cholangiofibrosis and subsequent high rate of liver cancer31. We performed multimodal imaging 
of LEC rat injected with thiol-OS-MNP/Rho. The coronal view (Fig. 2Aa), 3-dimensional images (Fig. 2Ab and 
c and Supporting information movie S1) in the 3-dimensional spoiled gradient recalled acquisition (3D-SPGR) 
revealed a large tumor (marker with red circle) and some small nodules in the liver. The thiol-OS-MNP/Rho can 
enhance and detect the tumor and abnormalities of LEC rat liver in MRI clearly and non-invasively. These higher 
spatial resolutions could assist an indication to find the pathological region in FI.
As shown in Fig. 2B, and Supporting information movie S2a and S2b for transverse findings of T1- and 
T2-weighted MRI respectively, the T1- and T2-weighted MRI of the LEC rat liver revealed abnormal findings, but 
the findings were different from each other. On T2-weighted MRI, the liver showed a nodular high intensity area 
(Fig. 2Bb), but there was diffuse moderate intensity, not a nodular area in the T1-weighted MRI (Fig. 2Ba) at the 
same level of transverse view. At another level, the T1-weighted MRI showed a large nodular area with a moderate 
intensity (Fig. 2Bd) and a small nodular area with high intensity in the T2-weighted MRI (Fig. 2Be). These mod-
erate intensity areas in the T1-weighted were merged with those of the T2-weighted to compare their distribution 
(Fig. 2Bc, f). Some areas in the T1-weighted (red) were identical with the T2-weighted (green), but other larger 
www.nature.com/scientificreports/
3Scientific RepoRts | 7: 3953  | DOI:10.1038/s41598-017-04043-7
areas were not. As reported previously23, thiol-OS-MNP/Rho enhanced shortening of the T2 relaxation times, but 
not of the T1 relaxation times. Therefore it was possible that difference between T1-weighted and T2-weighted 
findings could be enhanced. The organosilica layer contains proton molecules in the propyl residue and many 
diamagnetic elements, such as carbon, sulfur, and silicon. These diamagnetic elements might enhance shortening 
of the T2 relaxation times, but not of the T1 relaxation times of thiol-OS-MNP/Rho. There were three patterns 
of MRI signal in the LEC rat liver, white, red, and green merged with red in merged image (Fig. 2Bc and f). 
We classified the white areas as containing a high amount of labeled cells at a similar level with normal liver. Red 
areas contained labeled cells lower than that of white areas, and green merged with red areas contained lower lev-
els of cells than that of the red area. The red areas and green merged with red areas indicated pathological areas. 
Correlation analysis between the T1- and T2-weighted images provided semi-quantitative information about the 
Figure 1. Preparation and characterization of thiol-OS-MNP/Rho. (A) Scheme of the formation and electron 
microscopic finding of thiol-OS-MNP/Rho. (B) Panel a shows the T1 and T2 weighted images that were 
obtained with spin echo and turbo spin echo seaquence, respectively. Acquisition patameters were as belows; 
(T1 weighted image) TR = 300 ms, TE = 10 ms, 3 mm thickness, FOV = 240 × 144 mm2, matrix = 256 × 108, 
NEX = 8, (T2 weighted image) TR = 5000 ms, TE = 89 ms, 3 mm thickness, FOV = 240 × 142 mm2, 
matrix = 448 × 160, NEX = 4. Panel b showed findings of bright field imaging (BF) and fluorescent imaging 
(FI). (c) Absorbance spectra of t-OSP/RhoB, rhodamine B, EMG707, and thiol organosilica particles without 
rhodamine B nor EMG707. (d) Comprehensive 3-dimentional analysis of the excitation, emission, and 
fluorescence intensities for rhodamine B and t-OS-MNP/Rho.
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distribution of labeled cells in pathological liver. Multimodal imaging with FI could further information about 
pathological areas as described below. In addition to multimodal imaging, a combination with physicochemical 
analysis such as inductively coupled plasma mass spectrometry (ICP-MS) for organs, tissues, and pathological 
areas would provide more quantitative information. Further studies are required for integrative evaluation system 
for the biodistribution of nanoparticles.
Mesoscopic multimodal imaging of pathological liver of LEC rats. The liver of LEC rats injected 
with thiol-OS-MNP/Rho was removed and observed by multipurpose zoom fluorescence microscopy. As shown 
in Fig. 3A, mesoscopic FI demonstrated predominant different findings between normal and pathological livers. 
Normal liver showed a fluorescent reticular hepatic lobular pattern (Fig. 3Ad and e) as the similar finding to that 
of normal mouse liver23. In the normal liver, there are liver lobules consisting of the liver cells (hepatocytes). 
The hepatocytes form cellular plates, and the space between these plates contains capillaries, the liver sinusoids. 
The liver sinusoids contain not only endothelial cells but also macrophages called as Kupffer cells. The Kupffer 
cells were located in the peripheral region of the liver lobule predominantly. Therefore the polygonal structures 
of the liver lobules in mesoscopic FI of LEC rats were enhanced by thiol-OS-MNP/Rho in Kupffer cells. In this 
study using rats, FI showed reticular patterns based on the normal histological structure (Fig. 3Ad and e) too, but 
pathologic liver did not show clear reticular lobular patterns (Fig. 3Ad and f). In addition pathologic liver showed 
lower general fluorescent intensity compared with normal liver (Fig. 3Ad). These findings indicated an alteration 
of structural change of liver tissue and a decrease of the number and/or the uptake of Kupffer cells in at least the 
surface area of liver. There were heterogeneous distributions of labeled cells without clear reticular lobular pat-
terns (Fig. 3Af) as compared with that of normal liver (Fig. 3Ae). The distribution of labeled cells of pathologic 
liver showed larger clusters than that of normal liver lobule. Any relation between these large clusters and specific 
findings, such as protrusions or dents on the surface, were not found (Fig. 3Ai).
Figure 3B shows the surface of pathologic liver with higher magnification. There were white nodules marked 
with asterisks and open circle on the surface in the bright field image (Fig. 3Ba). The surface of the pathologic 
liver showed a heterogeneous distribution of labeled cells in FI (Fig. 3Bc). The areas of white nodules indicated by 
open circle showed a higher number of fluorescence labeled cells, but the areas marked with asterisks had a lower 
number, as shown in the merged image (Fig. 3Be). These results demonstrated that the findings of white nodules 
Figure 2. In vivo MRI of LEC rats injected thiol-OS-MNP/Rho. LEC rats (57 weeks) were injected 
intravenously with 0.9 mL of a solution containing 10 mg/mL of thiol-OS-MNP/Rho. After 1 day, rat was 
examined on MRI. (A) Coronal view (a), 3-dimensional images (b and c) in the 3D-SPGA MRI revealed a large 
tumor (marked with a red circle) and some small nodules in the liver. (B) The T2-weighted MRI (b), but not T1-
weighted MRI could detect a nodular high intensity area (marked white triangles) at the same transverse level. 
At another level, the T1-weighted (c) and T2-weighted (d) MRI showed large nodular area with a moderate 
intensity and a small nodular area with high intensity, respectively. The T1- and T2-weighted images (a,b 
and d,e) were merged (c and f, respectively). Some areas in the T1-weighted (red) were identical with the T2-
weighted (green) in liver.
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Figure 3. Mesoscopic FI of a pathological liver of LEC rat. (A) Normal (a,b,e) and pathologic (Path.) (a,c,f) 
liver were observed on bright field (a–c) and FI (d–f). Normal liver showed a fluorescent reticular hepatic 
lobular pattern (d and e), but the pathologic liver did not (d and f). Panels (g),(h) and (i) are merged images of 
(a) and (d),(b) and (e) and (c) and (f), respectively. Scale bars:  (a,d,g) 2 mm, (b,c,e,f,i) 1 mm. (B) The pathologic 
liver was observed with higher magnification. There were white nodules marked with asterisks and open circle 
in the bright field image (a). The surface of the pathologic liver showed a heterogeneous distribution of labeled 
cells in the FI (c). Panels (e) is merged images of (a) and (c). Areas indicated by a white box in panel (a,c,e) 
were observed with high magnification. Some vessels (V) were observed in the bright field image (b). Areas 
with a lower distribution of labeled cells (white triangle) were observed in FI (d). The merged image of (b) and 
(d) revealed that there were higher numbers of labeled cells around the vessels (V) than far from vessels (white 
triangle) (f). Scale bars:  (a,c,e) 2 mm, (b,d,f) 1 mm.
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in the bright field could not relate the distribution of labeled cells in FI. There were differences between the bright 
field and fluorescent imaging. The nodules marked with asterisks would show high contrast in the MRI because 
of labeled cell decrease. But the nodule marked with open circle would show normal contrast on MRI because of a 
lot of labeled cell. It is possible that these “differential” multimodal imaging would provide further understanding 
the relation between macrophages and tumor progression.
An area indicated in a white box showed some vessels on the bright field image (Fig. 3Bb) and indicated an 
area with a lower distribution of labeled cells compared with those of its surrounding in FI (Fig. 3Bd). The merged 
image (Fig. 3Bf) revealed that there were higher numbers of labeled cells around vessels than far from vessels 
(white triangle). These findings indicated that the distributions of labeled cells were related with the vessels in 
this area. As shown in the movie (Supporting information movie S3) of Fig. 3B, the labeled cells in the liver were 
detected using real time mesoscopic FI. This movie demonstrates a real time detection of various pathologi-
cal findings from low to high magnifications. These findings revealed high possibilities to develop mesoscopic 
FI-guided surgical treatment using fluorescent NPs. The mesoscopic FI of pathological liver of LEC rats revealed 
predominant differences from that of normal liver. This is the first report describing pathological mesoscopic FI 
of liver using FNPs. The mesoscopic FI of the surface fluorescence patterns and distributions of labeled cells of 
various diseases, and their alterations with the progress of diseases, would be useful for “macrophage imaging”. 
Mesoscopic FI is a novel imaging approach to detect and to evaluate pathological regions. In addition, mesoscopic 
FI would enable a correlation of the macroscopic findings in MRI and the microscopic findings of microscopy. 
However further studies to understand these findings are required, mesoscopic FI would be a novel diagnostic 
technique and an assistive technology for surgery and tissue-specific treatment.
Next, we observed the sectioned pathological liver of LEC rat by using FI and MRI to evaluate the correlation 
between these two modalities. As shown in Fig. 4Aa, the section of the pathologic liver showed a white nodule 
inside a bright field image. The white nodule was detected in the T2-weighted MRI as a round signal (Fig. 4Ab, 
and the Supporting information movie 3). These findings demonstrated that the macroscopic multimodal imag-
ing of MRI and bright field image were identical. As shown in Fig. 4B, the white nodule and its surrounding area 
were observed by FI. The peripheral area of the white nodule showed a larger number of labeled cells than those of 
the outside area (Fig. 4Bb). The central area of the white nodule did not show many labeled cells (Fig. 4Bb and e). 
The merged images (Fig. 4Bc and f) showed differences in the number of labeled cells among the outside, periph-
eral region, and central region of the white nodule. The section of pathologic liver showed peripheral and circular 
distributions of the labeled cells in the tumor. The region specific localization of the macrophages in the white 
nodule was detected using mesoscopic FI. These findings demonstrated that mesoscopic FI of the section pro-
vided further information about the distribution of the macrophages in tumors. Macrophages are associated with 
various pathological changes, such as inflammatory diseases and tumors32–36. In tumor biology, macrophages 
that infiltrate the tumor stroma are called tumor-associated macrophages (TAMs). Several papers reported that 
TAMs promote cancer cell growth, invasion, metastasis, angiogenesis, and suppression of antitumor immunity. 
Furthermore an increased number of TAMs is frequently correlated with angiogenesis, metastasis, and poor 
prognosis37–39. Therefore, a relation between macrophages and tumors is very important. The mesoscopic FI of 
pathological liver has high potential to understand the importance of macrophage localization in tumors and its 
relation with tumor progression.
We performed correlation analysis between optical imaging and MRI mesoscopic findings of sectioned patho-
logical liver ex vivo (Fig. 4C). Compared with the size of the white nodule in the bright field image (Fig. 4Ca), 
that of the signal of the MRI (Fig. 4Cb) was smaller. The merged image (Fig. 4Cc) also revealed a size difference 
between the findings of bright field imaging and that of MRI. They display “differential” mesoscopic multimodal 
imaging. The FI (Fig. 4Cd) showed a peripheral and circular distribution of labeled cells in the nodule of the 
bright field image. The merged images of the MRI and FI (Fig. 4Ce and f) demonstrated that the MRI signals were 
surrounded by FI signals. These findings indicated that the peripheral and circular distribution of the labeled 
cells in the white nodule made the signal on the MRI smaller than that in the bright field image. The “differential” 
mesoscopic multimodal imaging is important for understanding tumor size evaluation in MRI.
Histological FI of the Pathological Liver of the LEC Rats. The microscopic findings of the liver of the 
LEC rats injected with thiol-OS-MNP/Rho were observed using a virtual slide system. As shown in Fig. 5, the HE 
section demonstrated that liver lobules containing cellular plates were directed from the periphery of the liver 
lobules to the central veins on the left side of the slide at lower magnification (Fig. 5a). On the right side, there 
was hyperplasia of ductules surrounded by fibrous tissue, indicating cholangiofibrosis (Fig. 5a,d and g). These 
fibrotic changes might contribute a heterogeneous distribution of the labelled cells. There were a larger number 
of labeled cells in the normal area on the left side than in the cholangiofibrosis area on the right side (Fig. 5b). The 
merged findings revealed that the cholangiofibrosis area did not contain as many labeled cells as compared with 
that of the normal area (Fig. 5c,f and i). At higher magnification, some labeled cells were detected in the cholan-
giofibrosis area (Fig. 5g–i). The labeled cells were located near vessels (V) but not near bile ducts (BD) (Fig. 5f 
and i). These findings indicated that the localization of labeled cells was related with vessels in the pathological 
region of the LEC rat liver, and agreed with the finding of the mesoscopic FI (Fig. 3d–f). Histological FI using 
thiol-OS-MNP/Rho demonstrated that the distribution of labeled cells was related with the pathological findings. 
In previous paper, we reported that heterogeneous uptakes of Kupffer cells in mouse liver for thiol-OS-MNP/Rho 
using anti-CD68 antibody23. Some labeled cells were immunostained with anti-CD68 antibody, but some not. 
And some CD68 positive cells did not show fluorescence of thiol-OS-MNP/Rho. Therefore it should be noted 
that non-labeled cells with thiol-OS-MNP/Rho would be considered for further study to understand the relation 
between macrophage and tumor tissue. In addition, further investigations were required to understand the cel-
lular uptake behavior of labeled cells. The distribution and behavior such as uptake kinetics would provide fur-
ther characteristics and specificity of labeled cells in pathological regions. Correlative light electron microscopy 
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(CLEM) including intravital fluorescent imaging, 3-dimentional analysis with de-colorization and confocal 
microscopy, transmission and scanning electron microscopy would be useful for not only in vitro as reported 
previously26, 27 but also in vivo evaluation. CLEM for in vivo is under developing.
A pathological liver of an LEC rat has various pathological findings. Further correlative studies would provide 
more relations between the pathological findings and the distribution of labeled cells. The accumulations of cor-
relation study between histological FI and mesoscopic multimodal imaging, and between mesoscopic multimodal 
imaging and MRI, might find a link between pathological diagnosis and MRI via mesoscopic imagings. These 
links would allow MRI pathological diagnosis without biopsy using thiol-OS-MNP/Rho.
In conclusions, thiol-OS-MNP/Rho demonstrated mesoscopic multimodal imaging of hepatic tumor success-
fully. The thiol-OS-MNP/Rho could enhanced tumor nodule in liver of LEC rat on in vivo MRI non-invasively 
and semi-quantitatively, and revealed abnormal fluorescent pattern of pathological liver on mesoscopic FI. 
Mesoscopic imaging of ex vivo pathological liver on MRI and FI revealed “differential” multimodal imaging 
from bright field image, and could provide additional information such as peripheral distribution of labeled 
Figure 4. Mesoscopic multimodal imaging of a sectioned liver of LEC rat. (A) The section of the pathologic 
liver showed a white nodule in the bright field image (a), and in the T2-weighted MRI (b). (B) The peripheral 
area (p) of the white nodule were observed on bright field (a and d) and on FI (b and e). The merged images (c 
and f) showed differences in the number of labeled cells among outside (o), peripheral (p), and central (cn) area 
of the white nodule. Scale bars:  (a–c) 1 mm, (d–f) 0.25 mm. (C) Correlation analysis between the FI and MRI 
findings of the sectioned pathological liver. Compared with the bright field image (a), the findings of the MRI 
(b) and the merged image (c) showed that the size of the nodular area in the MRI was smaller than that of the 
bright field image. The merged images of the MRI and FI demonstrated the MRI signals were surrounded by FI 
signal (e and f). Scale bars:  (a–e) 1 mm, (f) 0.5 mm.
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cells in invisible pathological area on MRI. Histological FI revealed the distribution of labeled cells associated 
with pathological findings, and relations with mesoscopic FI. These results demonstrated that imaging using 
thiol-OS-MNP/Rho provided seamless and sequential “identical” multimodal imaging of pathological tissue. 
In addition, we demonstrated the difference between the findings of bright field imaging and that of MRI. We 
would like to emphasize that not only “identical” but also “differential” multimodal imaging are very useful to 
evaluate and understand pathological regions. Multimodal imaging including mesoscopic “macrophage imag-
ing” in liver would provide new insight and have great possibilities to develop advanced imaging and innovative 
nanomedicine.
Methods
Materials. MPMS and rhodamine B were purchased from Sigma-Aldrich Chemical co, (St. Louis, MO). 
MNPs EMG606 was from Ferrotec corp. (Tokyo, Japan). Ethyl alcohol and 28% NH4OH from Wako Fine 
Chemicals Inc. (Osaka, Japan).
Preparation of thiol-organosilica nanoparticles containing MNP and Rhodamine B. The mix-
ture of 12.5 mM MPMS, 0.1% EMG707, 2.0 mM rhodamine B, and 27% NH4OH, was incubated to grow the 
organosilica layer as reported previously23. After incubation, the reaction mixture was subjected to centrifugation 
to remove remaining reagents, and the pellet was sonicated. The particles were washed extensively with distilled 
water.
Characterization of thiol-OS-MNP/Rho. Relaxation times (T1 and T2) of NPs were measured with a 3-T 
PET/MR equipment (Biograph mMR, Siemens Healthcare, Erlangen, Germany) with 12ch head coil. Phantom 
materials containing of various concentrations of thiol-OS-MNP/Rho (0, 1.56 3.12, 6.25, 12.5, 25, and 50 µg/
mL) with 1.5% agar were prepared. T1 relaxation time of the phantom was calculated using the images obtained 
Figure 5. Histological FI of the pathological liver of the LEC rat. The HE section demonstrated liver lobules 
containing cellular plates were directed from the periphery of the liver lobules to the central veins (CV) on 
the left side of the slide at lower magnification (a). On the right side, there was hyperplasia of the ductules 
surrounded by fibrous tissue, indicating cholangiofibrosis (a,d and g). There were a larger number of labeled 
cells in the normal area on the left side than in the cholangiofibrosis area on the right side (b). The merged 
findings revealed that the cholangiofibrosis area did not contain as many labeled cells as the normal area (c,f and 
i). At higher magnification of the areas marked with rectangles (d–f), some labeled cells were detected in the 
cholangiofibrosis area (g–i). The labeled cells were located near the vessels (V) but not near the bile ducts (BD) 
(f and i). Scale bars:  (a–c) 1 mm, (d–f) 0.5 mm, (g–i) 0.1 mm.
www.nature.com/scientificreports/
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with a number of turbo inversion recovery sequences with different inversion times (TI) of 100, 200, 400, 800, 
1000, 1500, 2000, and 3000 ms, a repetition time (TR) of 3000 ms, echo time (TE) of 12 ms, 3 mm thickness, FOV 
240 mm2, matrix of 192, and NEX 1. T2 relaxation time was also calculated using the images obtained with a 
turbo spin echo sequence having fixed TR of 4000 ms and various TE values of 13.3, 26.6, 39.9, 53.2, 66.5, 79.8, 
93.1, and 106.4 ms, FOV 240 mm2, matrix of 192, and NEX 1. All analyses and calculations of relaxation times 
were performed with Image J (NIH, Bethesda, MD) and Microsoft Excel 2013. R1 and R2 were calculated using 
these calculated T1 and T2 values, respectively.
Fluorescence in a tube containing 0.1 mg/ml thiol-OS-MNP/Rho was observed with a multi-purpose zoom 
microscope (AZ100M, Nikon, Kanagawa, Japan) equipped with a 100-W mercury lamp as a light source and a 
CCD camera (Digital sight DS-Ri1, Nikon, Kanagawa, Japan). Excitation and emission wavelengths were cho-
sen as 540 and 605 nm, respectively. The absorbance of the solution containing 0.05 mg/ml thiol-OS-MNP/Rho, 
20 µM Rhodamine B, 0.05 mg/ml EMG707, and 0.05 mg/ml organosilica particles without rhodamine B nor 
EMG707 were measured with a V-730iRM spectrometer (JASCO, Tokyo, Japan). The fluorescent intensities of 
2 µM Rhodamine B solution and 0.1 mg/ml thiol-OS-MNP/Rho solution were obtained with an F-4500 fluores-
cence spectrophotometer (Hitachi, Tokyo, Japan).
MRI of LEC Rats Injected thiol-organosilica nanoparticles containing MNP and Rhodamine B. 
All experiments were performed in accordance with Tokushima University institution’s guidelines for ani-
mal care and use. All experimental protocols were approved by the animal research committee of Tokushima 
University. LEC rats (57 weeks) were injected intravenously with 0.9 mL of a solution containing 10 mg/mL of 
thiol-OS-MNP/Rho, respectively. After 1 day, these rats were examined on MRI. MRI images were performed 
using a 3-T Signa Excite HDxt (GE Healthcare, Milwaukee, WI, USA) with 8ch head coil. MRI pictures were 
reconstructed using OsiriX software (OsiriX Foundation, Geneva, Switzerland).
Mesoscopic Fluorescent Imaging and Histological Observation of Livers of LEC Rats. The livers 
of LEC rats injected thiol-OS-MNP/Rho were observed by using multi-purpose zoom microscope. These livers 
were fixed with 4% paraformaldehyde in 0.1 mM phosphate buffer (pH 7.4) for 4 h and then rinsed sequentially 
with PBS containing 10, 15, and 20% sucrose for 4 h. The tissues thus fixed were placed in OCT compound, and 
frozen at −80 °C. Frozen sections (6-μm thickness) were prepared with a cryostat and mounted on glass slides. 
The section slides were scanned with a NanoZoomer HT slide scanner with NanoZoomer Digital Pathology 
Scanner System software (Hamamatsu Photonics KK, Shizuoka, Japan). After scans in fluorescence mode, the 
liver sections were stained with hematoxylin and eosin, and then were scanned in bright-field mode. The analysis 
of digital slides was preformed with NDP Viewer Dual (Nano Zoomer Digital Pathology, Hamamtsu Photonics 
KK, Shizuoka, Japan).
Mesoscopic MRI of the Liver of LEC Rat. The fixed liver of LEC rat was sectioned into small piece. MRI 
images were performed using a MR VivoLVA (DS Pharma Biomedical Co., Ltd, Osaka, Japan). Three-dimensional 
MRI pictures were reconstructed using OsiriX software (OsiriX Foundation, Geneva, Switzerland).
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